Literature DB >> 21665141

Oncogene-induced mitotic stress: p53 and pRb get mad too.

Marcos Malumbres1.   

Abstract

Oncogenic signaling frequently results in unscheduled overexpression of cell cycle proteins and replicative stress. In this issue of Cancer Cell, Schvartzman et al. show that inactivation of p53 or pRb induces Mad2, and the overexpression of this mitotic checkpoint protein is a necessary event during oncogene-induced mitotic stress.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Year:  2011        PMID: 21665141     DOI: 10.1016/j.ccr.2011.05.023

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  15 in total

Review 1.  A role of WT1 in cell division and genomic stability.

Authors:  Jayasha Shandilya; Stefan G E Roberts
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 2.  Killing cells by targeting mitosis.

Authors:  E Manchado; M Guillamot; M Malumbres
Journal:  Cell Death Differ       Date:  2012-01-06       Impact factor: 15.828

Review 3.  Targeting tumour-supportive cellular machineries in anticancer drug development.

Authors:  Matthias Dobbelstein; Ute Moll
Journal:  Nat Rev Drug Discov       Date:  2014-03       Impact factor: 84.694

4.  In vivo overexpression of Emi1 promotes chromosome instability and tumorigenesis.

Authors:  S Vaidyanathan; K Cato; L Tang; S Pavey; N K Haass; B G Gabrielli; P H G Duijf
Journal:  Oncogene       Date:  2016-04-11       Impact factor: 9.867

5.  A centrosomal route for cancer genome instability.

Authors:  Guillermo de Cárcer; Marcos Malumbres
Journal:  Nat Cell Biol       Date:  2014-06       Impact factor: 28.824

6.  Cancer cells preferentially lose small chromosomes.

Authors:  Pascal H G Duijf; Nikolaus Schultz; Robert Benezra
Journal:  Int J Cancer       Date:  2012-11-26       Impact factor: 7.396

7.  Mitotic Stress and Chromosomal Instability in Cancer: The Case for TPX2.

Authors:  Ignacio Pérez de Castro; Marcos Malumbres
Journal:  Genes Cancer       Date:  2012-11

8.  Orthogonal targeting of EGFRvIII expressing glioblastomas through simultaneous EGFR and PLK1 inhibition.

Authors:  Ying Shen; Jie Li; Masayuki Nitta; Diahnn Futalan; Tyler Steed; Jeffrey M Treiber; Zack Taich; Deanna Stevens; Jill Wykosky; Hong-Zhuan Chen; Bob S Carter; Oren J Becher; Richard Kennedy; Fumiko Esashi; Jann N Sarkaria; Frank B Furnari; Webster K Cavenee; Arshad Desai; Clark C Chen
Journal:  Oncotarget       Date:  2015-05-20

9.  Inhibition of Skp2 sensitizes lung cancer cells to paclitaxel.

Authors:  Tonghai Huang; Lin Yang; Guangsuo Wang; Guanggui Ding; Bin Peng; Yuxin Wen; Zheng Wang
Journal:  Onco Targets Ther       Date:  2017-01-18       Impact factor: 4.147

Review 10.  Multi-layered cancer chromosomal instability phenotype.

Authors:  Anna V Roschke; Ester Rozenblum
Journal:  Front Oncol       Date:  2013-12-11       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.